March 2024: The Food and Drug Administration has granted approval for mirvetuximab soravtansine-gynx (Elahere, ImmunoGen, Inc. [now a part of AbbVie]) to be used in adult patients with FRα positive, platinum-resistant epithelial ..
March 2023: Brief Summary: The purpose of this clinical trial is to find out if anti-MESO antigen receptor CAR T-cell therapy can be used to treat epithelial ovarian cancer that has come back or stopped responding to other..
2022 yil noyabr: Oldindan birdan uchgacha tizimli davolash rejimidan o‘tgan va folat retseptorlari alfa (FR) musbat, platinaga chidamli epiteliy tuxumdon, fallopiya naychasi yoki qorin pardaning birlamchi saratoni bo‘lgan kattalar bemorlari uchun F..
2022 yil may: Trametinib takrorlanuvchi, past darajadagi seroz tuxumdon saratoni (Mekinist) uchun yangi parvarish standartiga aylanishi mumkin. The Lancet jurnalining 2022 yil fevral sonida chop etilgan tadqiqot natijalariga ko'ra, trametinib ikkala kimyoterapiyani ham, ..
Yanvar 2022: Pafolacianine (Cytalux, On Target Laboratories, LLC), optik tasvirlash agenti tuxumdon saratoni bilan og'rigan kattalar bemorlari uchun oziq-ovqat va farmatsevtika idorasi tomonidan litsenziyalangan.
Ko'krak va tuxumdonlar saratoni Agar siz ko'krak va tuxumdonlar saratoniga chalingan bo'lsangiz, genetik testdan o'tganingizdan so'ng siz BRCA1 / 2 mutatsiyasining saratoni ekanligingizni aniqlaysiz va hayotingiz saqlanib qoladi. Global Oncolog ma'lumotlariga ko'ra ..
2021 yil iyul: Saraton kasalligini davolashda eng so'nggi dorilarni ko'rib chiqing. Har yili, sinovlar va boshqa muhim omillarni o'rganib chiqqandan so'ng, USFDA dori-darmonlarni tasdiqlaydi va shuning uchun saraton bemorlari endi davolanish juda yaqin ekanligiga ishonishlari mumkin. ..